Breast Cancer Conference | Breast Cancer Summit | European Breast Cancer Webinars 2020 | 2020

Meet Inspiring Speakers and Experts at our 3000+ Global Events with over 1000+ Conferences, 1000+ Symposiums and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series : World’s leading Event Organizer

Conference Series Conferences gaining more Readers and Visitors

Conference Series Web Metrics at a Glance

  • 3000+ Global Events
  • 100 Million+ Visitors
  • 75000+ Unique visitors per conference
  • 100000+ Page views for every individual conference

Unique Opportunity! Online visibility to the Speakers and Experts

Recommended Global Oncology & Cancer Webinars & Conferences

Asia Pacific & Middle East
Canada

Asian Breast Cancer 2020

About Us

Conference Series llc LTD invites all the participants from all over the world to attend "11th Asian Breast Cancer: Screening, Treatment & Management" during November 16-17, 2020. Which includes prompt keynote presentations, Oral talks, Poster presentations and Exhibitions. The conference promises an outstanding scientific program featuring many well-known and thought-provoking speakers.

ASIAN BREAST CANCER 2020 is the abnormal growth of the cells lining the breast lobules or ducts. These cells grow uncontrollably and have the potential to spread to other parts of the body. Both men and women can develop breast cancer, although it is uncommon in men.

ASIAN BREAST CANCER 2020 aims to provide optimal health and healthcare to adolescent girls and women, with focus on the prevention, diagnosis of Breast Cancer, as well as related Genetics, Pathophysiology, Epidemiology, Clinical Reports etc. The shift in medicine and healthcare from management of disease towards promoting wellness is a keystone in addressing the upstream caused of disease and ensuring that all women have equal opportunities.  Therefore, it is very appropriate to bring together the experts in the field from all over the globe as we share experiences and knowledge and work together on reducing the risk and creating awareness of Breast Cancer.

Why to attend???

With members from around the world focused on learning about Breast Cancer and treatment and who tackle key issues facing patients throughout the continuum of the breast cancer journey; this is your best opportunity to reach the largest assemblage of participants from the Breast Cancer community. Conduct presentations, distribute information, meet with current and potential scientists, make a splash with new discoveries in the breast cancer treatment and diagnosis, and receive name recognition at this 2-day event. World-renowned speakers, the most recent techniques, developments, and the newest updates in breast cancer, woman psychology, women disorders are hallmarks of this conference.

Target Audience:

  • Radiologist
  • Radiation Oncologist
  • Radiation Therapist
  • Medical Oncologist
  • Breast Care Nurse
  • Surgeon
  • Reconstructive (plastic) Surgeon
  • Lymphoedema Therapist
  • Breast Cancer Surgeons, pathologists
  • Nurse Practitioners/Nurses
  • Healthcare Faculty
  • Medical Colleges
  • Healthcare Associations and Societies
  • Business Entrepreneurs
  • Training Institutes
  • Manufacturing Medical Devices Companies
  • Data Management Companies

Session/Tracks

Conference Series llc LTD  invites all the participants from all over the world to attend “11th Asian Breast Cancer: Screening, Treatment & Management” during November 16-17, 2020 which includes prompt keynote presentations, Oral talks, Poster presentations and Exhibitions. The conference promises an outstanding scientific program featuring many well-known and thought-provoking speakers.

ASIAN BREAST CANCER 2020 aims to provide optimal health and healthcare to adolescent girls and women, with focus on the prevention, diagnosis and management of Breast Cancer, Pathophysiology, Epidemiology , Chemotherapy, prevention and management, Clinical tails in Breast Cancer, etc.

Track 1: Breast Cancer Nursing:

Nursing United Nations agency have data of cancer basics and area unit in an exceedingly position to frequently administer therapy and biotherapy ought to take the ONS/ONCC therapy Biotherapy Certificate Course, that provides sixteen contact hours, AN ONCC certificate of other qualification, and a supplier card.

Nursing United Nations agency area unit new medical specialty, administering or about to administer therapy or biotherapy on a less-frequent basis, or caring for patients receiving therapy ought to take the therapy Biotherapy: Fundamentals of Administration Course, that provides nine.1 contact hours and a therapy supplier card.

Track 2: Breast Cancer Nursing:

There territory unit numerous sorts of carcinoma. the first regular assortments territory unit ductal threatening neoplastic infection set up, intrusive ductal harmful neoplastic sickness, and obtrusive flap dangerous neoplastic malady.

The kind of carcinoma is set by the exact cells inside the bosom that territory unit influenced. Most bosom diseases region unit carcinomas. Carcinomas zone unit tumors that start inside the creature tissue cells that line organs and tissues all through the body. Some of the time, a great extra explicit term is utilized. for instance, most bosom tumors region unit a kind of threatening neoplastic ailment known as glandular malignant growth, that begins in cells that structure up organs (glandular tissue). Bosom adenocarcinomas start inside the channels (the milk pipes) or the lobules (milk-delivering organs).

The sort of bosom disease is dictated by the particular cells in the bosom that are influenced. Most bosom malignant growths are carcinomas. Carcinomas are tumors that begin in the epithelial cells that line organs and tissues all through the body. Once in a while, a considerably progressively explicit term is utilized. For instance, most bosom diseases are a sort of carcinoma called adenocarcinoma, which begins in cells that make up organs (glandular tissue). Bosom adenocarcinomas begin in the pipes (the milk conduits) or the lobules (milk-creating organs).

There are other, less normal, sorts of bosom malignancies, as well, for example, sarcomas, phyllodes, Paget malady, and angiosarcomas which begin in the cells of the muscle, fat, or connective tissue.

Track 3: Reconstruction of breast cancer: 

Bosom remaking medical procedure is the production of another bosom shape, or hill, utilizing medical procedure. It might be done after expulsion of an entire bosom (mastectomy) or part of the (bosom saving medical procedure).

You can have reproduction in the meantime as bosom malignant growth medical procedure (prompt recreation), or months or years after the fact (deferred remaking). Bosom reproduction regularly includes a few activities to give you the most ideal result

Track 4: Mastectomy: 

A mastectomy is the evacuation of the majority of the tissue from one or the two bosoms. Mastectomies are principally performed to evacuate or forestall bosom disease.

There are different types of mastectomy to deal with different medical situations.

  • Total (simple) mastectomy
  • Double mastectomy
  • Radical mastectomy
  • Modified radical mastectomy
  • Skin-sparing mastectomy
  • Nipple-sparing mastectomy

Track 5: Breast Cancer therapies: 

This section tells you the treatments that square measure the quality of take care of early-stage and domestically advanced carcinoma. “Standard of care” suggests that the most effective treatments illustrious. once creating treatment arrange selections, patients square measure inspired to contemplate clinical trials as associate possibility. A test could be a analysis study that tests a replacement approach to treatment. Doctors wish to be told whether the new treatment is safe, effective, and presumably higher than the quality treatment. Clinical trials will check a replacement drug and the way usually it ought to incline, a replacement combination of ordinary treatments, or new doses of ordinary medication or alternative treatments. A treatment arrange could be a outline of your cancer and also the planned cancer treatment. it's meant to convey basic info concerning your case history to any doctors WHO can take care of you throughout your period. Before treatment begins, raise your doctor for a duplicate of your treatment arrange. you'll conjointly give your doctor with a duplicate of the ASCO Treatment arrange type to fill out.

Track 6: Treating Breast Cancer with Therapies: 

Not all girls with carcinoma can want chemo, however there are many things during which chemo could also be recommended: After surgery (adjuvant chemotherapy): Adjuvant chemo is employed to do to kill any cancer cells that may are left behind or have unfold however cannot be seen, even on imaging tests. If these cells were allowed to grow, they might kind new tumors in alternative places within the body. Adjuvant chemo will lower the chance of carcinoma returning. Before surgery (neoadjuvant chemotherapy): Neoadjuvant chemo will be accustomed attempt to shrink the neoplasm therefore it will be removed with less in depth surgery. due to this, neoadjuvant chemo is usually accustomed treat cancers that are too huge to be removed by surgery at the time of identification (called domestically advanced cancers). Also, by giving chemo before the neoplasm is removed, doctors will higher see however the cancer responds to that. If the primary set of chemo medication doesn’t shrink the neoplasm, your doctor can recognize that alternative medication is required. It ought to additionally kill any cancer cells that have unfold however cannot be seen. similar to adjuvant chemo, neoadjuvant chemo will lower the chance of carcinoma returning. For advanced breast cancer: Chemo will be used because the main treatment for girls whose cancer has unfold outside the breast and underarm space, either once it's diagnosed or once initial treatments. The length of treatment depends on however well the chemo is functioning and the way well you tolerate it.

Track 7: Treatment and Side effects of Breast Cancer:

In recent years, there is been associate degree explosion of life-saving treatment advances against carcinoma, transfer new hope and excitement. rather than just one or 2 choices, these days there is an amazing menu of treatment selections that fight the complicated mixture of cells in every individual cancer. the selections — surgery, then maybe radiation, secretion (anti-estrogen) medical aid, and/or therapy — will feel overwhelming.

Track 8: Breast Cancer: Clinical Trials:

Whether a replacement medical aid or take a look at becomes a part of normal treatment for carcinoma depends  for the most part on run results. For example, clinical trials showed the advantage of internal secretion therapies and trastuzumab (Herceptin) and these medication square measure currently a part of normal carcinoma treatment. Large randomized clinical trials square measure viewed because the best basis for creating treatment pointers. Clinical trials occur across the country (and round the world) in many sorts of medical centers and   hospitals.

Often, trials square measure funded by one agency just like the National Cancer Institute (a government agency) and square measure done at an equivalent time in several sites across the country. These square measures known as cooperative cluster clinical trials, and permit researchers to extend the number of individuals in a very given study. Dedicated physicians, researchers and alternative health professionals, likewise as hospitals, medical analysis centers and funders square measure all key to clinical trials. However, most vital square measure the participants.

Track 9: Clinical Staging of Breast Cancer:

The assurance of whether your malignant growth is obtrusive or noninvasive (in situ), the data accumulated from your restorative history and physical examination, just as an assessment of your underlying bosom imaging (mammogram, ultrasound, and bosom MRI) are altogether viewed as while recognizing your bosom disease's clinical stage. When that organize is distinguished, your doctor will almost certainly propose the most suitable treatment choices.

Noninvasive Cancer Staging: Noninvasive bosom malignancy is delegated Tis, where "is" represents in situ, or "set up." In situ tumors, which are contained and don't spread to lymph hubs or outside the bosom, are alluded to as "arrange 0."

Obtrusive Cancer Staging: Invasive tumors can possibly spread. The evaluated size of the malignancy and whether the disease seems to have spread to the lymph hubs can be resolved once the doctor analyzes the bosom and takes a gander at the bosom imaging, which for the most part incorporates a mammogram and ultrasound. In the event that you have manifestations that propose the malignant growth may have spread outside of the bosom and lymph hubs, extra tests might be requested. On the off chance that you have bone agony, these tests may incorporate a bone sweep or PET output.

Clinical vs Pathological Staging: Keep as a primary concern that the clinical stage may vary from the obsessive stage in light of the fact that once the disease has been carefully expelled the pathologist can gauge it definitely. The pathological stage may likewise contrast on the off chance that you get chemotherapy or hormone-blocking treatment before your bosom malignancy medical procedure (known as neoadjuvant chemotherapy and neoadjuvant hormonal treatment).

Track 10: Breast Cancer Radiation Therapy:

Some girls with carcinoma can want radiation, usually additionally to different treatments. the requirement for radiation depends on what form of surgery you had, whether your cancer has unfolded to the humour nodes or elsewhere in your body, and in some cases, your age. Tumours that are massive or involve the skin may also want radiation. you'll have only 1 form of radiation, or a mixture of various varieties.

Radiation treatment will be treatment with high-vitality beams, (for example, x-beams) or particles that demolish disease cells. 2 main forms of radiotherapy will be wont to treat breast cancer:  External beam radiation: this sort of radiation comes from a machine outside the body. Internal radiation (brachytherapy): For this treatment, a radioactive supply is place within the body for a brief time.

Track 11: Breast Cancer during Pregnancy:

It is doable to be diagnose with carcinoma throughout maternity, though it's rare and therefore the carcinoma isn't caused by the maternity. girls WHO area unit diagnosed with carcinoma throughout maternity have tremendous further strain because of concern for the protection of the unhatched kid. It is a traumatic and intensely tough state of affairs, however there's still hope for each mother and kid, because of the various treatment choices offered.

If you're pregnant and are diagnosed, make certain to speak rigorously along with your obstetrical care team yet as your medical specialty team, and it ne'er hurts to verify that they need open communication with one another. Your medical team can take further care in planning the treatment arrange that best controls the carcinoma whereas protective your unhatched kid.

Track 12: Male Breast Cancer Research:

Male carcinoma could be a relatively uncommon disease in men that starts from the bosom. Most cases of male carcinoma develop in men United Nations agency square measure sixty-five or over, though cases are recorded in men aged anyplace from five to ninety-three. The calculable 5-year survival rate for early-stage male carcinoma is sort of 100%. For mid-stage male carcinoma, it's 72-91 %, and for advanced-stage male carcinoma, there's twenty %   likelihood of survival once five years from detection. A man's period risk of developing carcinoma is concerning   one in one,000 thousand.

Market Analysis

Conference Series LLC Ltd is good to go to concentrate on the worldwide general wellbeing concerns. Conference Series LLC Ltd planned 1000+ yearly logical meetings, 2000+ international workshops, classes, presentations and symposia.

Conference series LLC Ltd breast cancer meetings would offer a ground-breaking worldwide gathering to energize exchange on the headways identified with avoidance, fix and restoration of cancer illness.

According to a new technical market research report, breast cancer diagnostic and drug technologies: Global markets (HLC106A) from BCC Research the market for predictive diagnostic and drug technologies concerning breast cancer was valued at $21.2 billion in 2011. This figure is projected to reach nearly $24.1 billion in 2016, a five-year compound annual growth rate (CAGR) of 2.5%. The global market for breast cancer diagnostic and drug technologies was about $20.8 billion in 2012. This market reached about $22.3 billion in 2014 and is expected to reach $27 billion in 2019, registering a compound annual growth rate (CAGR) of 4% through 2014-2019.

As per the market report most of the oncology & women’s health companies mainly invests in the following:

  • Breast Cancer Diagnostic and Drug Technologies
  • Cancer Vaccines
  • Biopsy Devices
  • Biological Therapies for Cancer Treatment

Breast Cancer Diagnostic and Drug Technologies:

  • The global market for breast cancer diagnostic and drug technologies was about $20.8 billion in 2012. This market reached about $22.3 billion in 2014 and is expected to reach $27 billion in 2019, registering a compound annual growth rate (CAGR) of 4% through 2014-2019.
  • Breast cancer drugs as a segment will grow from $10.2 billion in 2014 to nearly $13 billion by 2019 at a 5.0% CAGR for the period 2014-2019.
  • Quantitative immunofluorescence as a segment will grow from $6.5 billion in 2014 to $7.5 billion in 2019, increasing at a CAGR of 3.1% from 2014-2019.

Biological Therapies for Cancer Treatment:

  • The global market for biologic cancer treatment totaled $51.2 billion in 2014 and is expected to reach $66.4 billion in 2019, registering a compound annual growth rate (CAGR) of 5.4% for the period 2014-2019.
  • Monoclonal antibodies as a segment will grow from around $28.5 billion in 2014 to about $37.3 billion by 2019 at a 5.6% CAGR for the period 2014-2019.
  • Immunostimulants as a segment will grow from $14.8 billion in 2014 to $18.5 billion in 2019, increasing at a CAGR of 4.6% from 2014-2019.

Breast Cancer Research Review:

Breast cancer drug markets in the Asia-Pacific region look set to rise from 2014’s $1.9 billion figure to $3.4 billion by 2021, analysts predict. Breast cancer therapeutics in Asia-Pacific Markets to 2020 research report says, thanks to an increasing uptake of branded drugs in Asia-Pacific (APAC), the region’s breast cancer therapeutics market value was $1.5 billion in 2013 and is estimated to reach $2.5 billion by 2020, at a Compound Annual Growth Rate (CAGR) of 7.6%.

To Collaborate Scientific Professionals around the World

Conference Date November 16-17, 2020

For Sponsors & Exhibitors

sponsor@conferenceseries.com

Speaker Opportunity

Supported By

Archives of Surgical Oncology Oncology & Cancer Case Reports Cancer Science & Therapy

All accepted abstracts will be published in respective Conference Series International Journals.

Abstracts will be provided with Digital Object Identifier by